Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression |
https://doi.org/10.18632/oncotarget.24157
Jie Wang,
Han Cai,
Yue Xia,
Shiying Wang,
Likai Xing,
Chao Chen,
Yong Zhang,
Jie Xu,
Peihao Yin,
Yiming Jiang,
Ronghua Zhao,
Qingshong Zuo,
and Teng Chen
|
23320-23333 |
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells |
https://doi.org/10.18632/oncotarget.25101
Sabrina D’Agostino,
Delia Lanzillotta,
Mariaconcetta Varano,
Cirino Botta,
Antonio Baldrini,
Anna Bilotta,
Stefania Scalise,
Vincenzo Dattilo,
Rosario Amato,
Eugenio Gaudio,
Francesco Paduano,
Camillo Palmieri,
Rodolfo Iuliano,
Nicola Perrotti,
Cesare Indiveri,
Alfredo Fusco,
Marco Gaspari,
and Francesco Trapasso
|
23334-23348 |
The multifunctional protein YB-1 potentiates PARP1 activity and decreases the efficiency of PARP1 inhibitors
The multifunctional protein YB-1 potentiates PARP1 activity and decreases the efficiency of PARP1 inhibitors |
https://doi.org/10.18632/oncotarget.25158
Elizaveta E. Alemasova,
Konstantin N. Naumenko,
Tatyana A. Kurgina,
Rashid O. Anarbaev,
and Olga I. Lavrik
|
23349-23365 |
Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma
Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma |
https://doi.org/10.18632/oncotarget.25163
Richard Kim,
Domenico Coppola,
Emilie Wang,
Young Doo Chang,
Yuhree Kim,
Daniel Anaya,
and Dae Won Kim
|
23366-23372 |
Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors
Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors |
https://doi.org/10.18632/oncotarget.25169
María Rodríguez-Muñoz,
Pilar Sánchez-Blázquez,
and Javier Garzón
|
23373-23389 |
Pilot study of dovitinib in patients with von Hippel-Lindau disease
Pilot study of dovitinib in patients with von Hippel-Lindau disease |
https://doi.org/10.18632/oncotarget.25171
Patrick Pilié,
Elshad Hasanov,
Surena F. Matin,
Ashley H. Henriksen Woodson,
Valerie D. Marcott,
Shelly Bird,
Rebecca S. Slack,
Gregory N. Fuller,
Ian E. McCutcheon,
and Eric Jonasch
|
23390-23395 |
Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells
Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells |
https://doi.org/10.18632/oncotarget.25174
Eliana Noelia Alonso,
María Julia Ferronato,
María Eugenia Fermento,
Norberto Ariel Gandini,
Alejandro López Romero,
Josefina Alejandra Guevara,
María Marta Facchinetti,
and Alejandro Carlos Curino
|
23396-23412 |
A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2
A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2 |
https://doi.org/10.18632/oncotarget.25182
Marine Daures,
Mouhamed Idrissou,
Gaëlle Judes,
Khaldoun Rifaï,
Frédérique Penault-Llorca,
Yves-Jean Bignon,
Laurent Guy,
and Dominique Bernard-Gallon
|
23413-23425 |
Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity
Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity |
https://doi.org/10.18632/oncotarget.25193
Jacopo Junio Valerio Branca,
Mario Maresca,
Gabriele Morucci,
Matteo Becatti,
Ferdinando Paternostro,
Massimo Gulisano,
Carla Ghelardini,
Daniela Salvemini,
Lorenzo Di Cesare Mannelli,
and Alessandra Pacini
|
23426-23438 |
Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells
Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells |
https://doi.org/10.18632/oncotarget.25211
Bryan Oronsky,
Tony R. Reid,
Arnold Oronsky,
Scott Caroen,
Corey A. Carter,
and Pedro Cabrales
|
23439-23442 |
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma |
https://doi.org/10.18632/oncotarget.25215
Alessandro Broccoli,
Beatrice Casadei,
Alice Morigi,
Federico Sottotetti,
Manuel Gotti,
Michele Spina,
Stefano Volpetti,
Simone Ferrero,
Francesco Spina,
Francesco Pisani,
Michele Merli,
Carlo Visco,
Rossella Paolini,
Vittorio Ruggero Zilioli,
Luca Baldini,
Nicola Di Renzo,
Patrizia Tosi,
Nicola Cascavilla,
Stefano Molica,
Fiorella Ilariucci,
Gian Matteo Rigolin,
Francesco D'Alò,
Anna Vanazzi,
Elisa Santambrogio,
Roberto Marasca,
Lucia Mastrullo,
Claudia Castellino,
Giovanni Desabbata,
Ilaria Scortechini,
Livio Trentin,
Lucia Morello,
Lisa Argnani,
and Pier Luigi Zinzani
|
23443-23450 |
Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells
Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells |
https://doi.org/10.18632/oncotarget.25217
Takanori Hayashi,
Masahiro Hikichi,
Jun Yukitake,
Toru Wakatsuki,
Eiji Nishio,
Toshiaki Utsumi,
and Nobuhiro Harada
|
23451-23461 |
Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target
Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target |
https://doi.org/10.18632/oncotarget.25231
Danielle Brooks,
Alexandra Zimmer,
Lalage Wakefield,
L. Tiffany Lyle,
Simone Difilippantonio,
Fabio C. Tucci,
Stephane Illiano,
Christina M. Annunziata,
and Patricia S. Steeg
|
23462-23481 |
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer |
https://doi.org/10.18632/oncotarget.25235
Ari J. Rosenberg,
Derek A. Wainwright,
Alfred Rademaker,
Carlos Galvez,
Matthew Genet,
Lijie Zhai,
Kristen L. Lauing,
Mary F. Mulcahy,
John P. Hayes,
David D. Odell,
Craig Horbinski,
Srinadh Komanduri,
Marie-Pier Tetreault,
Kwang-Youn A. Kim,
and Victoria M. Villaflor
|
23482-23493 |
Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors
Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors |
https://doi.org/10.18632/oncotarget.25236
Rashmi Kumari,
Martin R. Silic,
Yava L. Jones-Hall,
Alexandra Nin-Velez,
Jer-Yen Yang,
Suresh K. Mittal,
and GuangJun Zhang
|
23494-23504 |
The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells
The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells |
https://doi.org/10.18632/oncotarget.25239
Loredana Zocchi,
Stephanie C. Wu,
Jie Wu,
Ken L. Hayama,
and Claudia A. Benavente
|
23505-23518 |
Breast cancer stem cell-like cells generated during TGFβ-induced EMT are radioresistant
Breast cancer stem cell-like cells generated during TGFβ-induced EMT are radioresistant |
https://doi.org/10.18632/oncotarget.25240
Julie Konge,
François Leteurtre,
Maud Goislard,
Denis Biard,
Sandrine Morel-Altmeyer,
Aurélie Vaurijoux,
Gaetan Gruel,
Sylvie Chevillard,
and Jérôme Lebeau
|
23519-23531 |
Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model
Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model |
https://doi.org/10.18632/oncotarget.25247
Ninh B. Doan,
Ha S. Nguyen,
Hisham S. Alhajala,
Basem Jaber,
Mona M. Al-Gizawiy,
Eun-Young Erin Ahn,
Wade M. Mueller,
Christopher R. Chitambar,
Shama P. Mirza,
and Kathleen M. Schmainda
|
23532-23542 |
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells |
https://doi.org/10.18632/oncotarget.25261
Stefano Volinia,
Valeria Bertagnolo,
Silvia Grassilli,
Federica Brugnoli,
Marco Manfrini,
Marco Galasso,
Cristian Scatena,
Chiara Maria Mazzanti,
Francesca Lessi,
Giuseppe Naccarato,
Adelaide Caligo,
Enzo Bianchini,
Quirino Piubello,
Enrico Orvieto,
Massimo Rugge,
Cristina Natali,
Domenico Reale,
Andrea Vecchione,
Sarah Warner,
Carlo Maria Croce,
and Silvano Capitani
|
23543-23553 |
Highly expressed placental miRNAs control key biological processes in human cancer cell lines
Highly expressed placental miRNAs control key biological processes in human cancer cell lines |
https://doi.org/10.18632/oncotarget.25264
Daniel Onofre Vidal,
Anelisa Ramão,
Daniel Guariz Pinheiro,
Bruna Rodrigues Muys,
Julio Cesar Cetrulo Lorenzi,
Cleidson de Pádua Alves,
Dalila Luciola Zanette,
Greice Andreotti de Molfetta,
Geraldo Duarte,
and Wilson Araújo Silva Jr
|
23554-23563 |
Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial
Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial |
https://doi.org/10.18632/oncotarget.25276
Juliana Noguti,
Alfred A. Chan,
Bradley Bandera,
Colin J. Brislawn,
Mladjan Protic,
Myung S. Sim,
Janet K. Jansson,
Anton J. Bilchik,
and Delphine J. Lee
|
23564-23576 |
miRNA122a regulation of gene therapy vectors targeting hepatocellular cancer stem cells
miRNA122a regulation of gene therapy vectors targeting hepatocellular cancer stem cells |
https://doi.org/10.18632/oncotarget.25280
Bijay Dhungel,
Charmaine A. Ramlogan-Steel,
Christopher J. Layton,
and Jason C. Steel
|
23577-23588 |
Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma
Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma |
https://doi.org/10.18632/oncotarget.25283
Aurélie Verney,
Alexandra Traverse-Glehen,
Evelyne Callet-Bauchu,
Laurent Jallades,
Jean-Pierre Magaud,
Gilles Salles,
Laurent Genestier,
and Lucile Baseggio
|
23589-23598 |
Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma
Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.25284
Alexey Surov,
Hans Jonas Meyer,
Karsten Winter,
Cindy Richter,
and Anna-Kathrin Hoehn
|
23599-23607 |
The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience
The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience |
https://doi.org/10.18632/oncotarget.25286
Alexandre Arsene-Henry,
Jean-Philippe Foy,
Magalie Robilliard,
Hao-Ping Xu,
Louis Bazire,
Dominique Peurien,
Philip Poortmans,
Alain Fourquet,
and Youlia M. Kirova
|
23608-23619 |
A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival
A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival |
https://doi.org/10.18632/oncotarget.25306
Colm Keane,
Joshua Tobin,
Dipti Talaulikar,
Michael Green,
Pauline Crooks,
Sanjiv Jain,
and Maher Gandhi
|
23620-23627 |
Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac
Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac |
https://doi.org/10.18632/oncotarget.25310
Yoko Goto,
Ryo Ashida,
Akira Nakamura,
Satoshi Itasaka,
Keiko Shibuya,
Mami Akimoto,
Nobutaka Mukumoto,
Shigemi Matsumoto,
Masashi Kanai,
Hiroyoshi Isoda,
Toshihiko Masui,
Yuzo Kodama,
Mitsuhiro Nakamura,
Kyoichi Takaori,
Takashi Mizowaki,
and Masahiro Hiraoka
|
23628-23635 |
Changes of signal transductivity and robustness of gene regulatory network in the carcinogenesis of leukemic subtypes via microarray sample data
Changes of signal transductivity and robustness of gene regulatory network in the carcinogenesis of leukemic subtypes via microarray sample data |
https://doi.org/10.18632/oncotarget.25318
Cheng-Wei Li,
Tzu-Ying Lai,
and Bor-Sen Chen
|
23636-23660 |
Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study
Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study |
https://doi.org/10.18632/oncotarget.25320
Pierre-Jean Lamy,
Brigitte Trétarre,
Xavier Rebillard,
Marie Sanchez,
Sylvie Cénée,
and Florence Ménégaux
|
23661-23669 |
Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma
Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma |
https://doi.org/10.18632/oncotarget.25330
Michael J. Hamilton,
Thomas Girke,
and Ernest Martinez
|
23670-23680 |
Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide |
https://doi.org/10.18632/oncotarget.25348
Kei Miyakawa,
Satoko Matsunaga,
Yutaro Yamaoka,
Mina Dairaku,
Kento Fukano,
Hirokazu Kimura,
Tomoyuki Chimuro,
Hironori Nishitsuji,
Koichi Watashi,
Kunitada Shimotohno,
Takaji Wakita,
and Akihide Ryo
|
23681-23694 |
Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis
Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis |
https://doi.org/10.18632/oncotarget.24923
Zhihui Zhang,
Haibiao Xie,
Daqiang Liang,
Lanbing Huang,
Feiguo Liang,
Qiang Qi,
and Xinjian Yang
|
23695-23703 |
Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials
Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials |
https://doi.org/10.18632/oncotarget.25281
Chintan Shah,
Rohit Bishnoi,
Yu Wang,
Fei Zou,
Harini Bejjanki,
Samip Master,
and Jan S. Moreb
|
23704-23717 |
Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis
Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis |
https://doi.org/10.18632/oncotarget.23891
Linghui Deng,
Shi Qiu,
Yan Yang,
Lu Wang,
Yuxiao Li,
Jing Lin,
Qiang Wei,
Lu Yang,
Deren Wang,
and Ming Liu
|
23718-23728 |
Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study
Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study |
https://doi.org/10.18632/oncotarget.25263
Yutaka Fujiwara,
Masayuki Takeda,
Noboru Yamamoto,
Kazuhiko Nakagawa,
Kaname Nosaki,
Ryo Toyozawa,
Chihiro Abe,
Ryota Shiga,
Kenji Nakamaru,
and Takashi Seto
|
23729-23737 |
Optimal hydration volume among high-risk patients with advanced congestive heart failure undergoing coronary angiography
Optimal hydration volume among high-risk patients with advanced congestive heart failure undergoing coronary angiography |
https://doi.org/10.18632/oncotarget.25315
Shi-Qun Chen,
Yong Liu,
Wei Jie Bei,
Ying Wang,
Chong-Yang Duan,
Deng-Xuan Wu,
Kun Wang,
Ping Yan Chen,
Ji-Yan Chen,
Ning Tan,
and Li-Wen Li
|
23738-23748 |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study |
https://doi.org/10.18632/oncotarget.25255
Sheng-Kai Liang,
Meng-Rui Lee,
Wei-Yu Liao,
Chao-Chi Ho,
Jen-Chung Ko,
and Jin-Yuan Shih
|
23749-23760 |
Stromal cells in breast cancer as a potential therapeutic target
Stromal cells in breast cancer as a potential therapeutic target |
https://doi.org/10.18632/oncotarget.25245
Samantha S. Dykes,
Veronica S. Hughes,
Jennifer M. Wiggins,
Henrietta O. Fasanya,
Mai Tanaka,
and Dietmar Siemann
|
23761-23779 |
p53 and metabolism: from mechanism to therapeutics
p53 and metabolism: from mechanism to therapeutics |
https://doi.org/10.18632/oncotarget.25267
Fernando M. Simabuco,
Mirian G. Morale,
Isadora C.B. Pavan,
Ana P. Morelli,
Fernando R. Silva,
and Rodrigo E. Tamura
|
23780-23823 |
Oxidative stress in female cancers
Oxidative stress in female cancers |
https://doi.org/10.18632/oncotarget.25323
Gloria M. Calaf,
Ulises Urzua,
Lara Termini,
and Francisco Aguayo
|
23824-23842 |
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression |
https://doi.org/10.18632/oncotarget.25377
Jian Ma,
Yanxin Fan,
Tingting Feng,
Fangjun Chen,
Zhipeng Xu,
Suqing Li,
Qingfeng Lin,
Xiaoting He,
Weihong Shi,
Yang Liu,
Zhihua Liu,
Bin Zhu,
and Xiufeng Cao
|
23843-23843 |
Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients
Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients |
https://doi.org/10.18632/oncotarget.25378
Shun-Ichiro Kageyama,
Keiji Nihei,
Katsuyuki Karasawa,
Takeshi Sawada,
Fumiaki Koizumi,
Shigeo Yamaguchi,
Shunsuke Kato,
Hidehiro Hojo,
Atsushi Motegi,
Katsuya Tsuchihara,
and Tetsuo Akimoto
|
23844-23844 |
Retraction: PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation
Retraction: PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation |
https://doi.org/10.18632/oncotarget.25033
Qiang Ma,
Xiuxiu Wu,
Jing Wu,
Huanwen Wu,
Ying Xiao,
Lili Wang,
Zhiyong Liang,
and Tonghua Liu
|
23845-23845 |